MedTrace Logo

Multiple Behavior Screening, Brief Intervention and Referral to Treatment (SBIRT) Model of Drug Abuse in Primary Care

NCT01439334 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2011-09-23

No results posted yet for this study

Summary

The primary purpose of this research is to develop and evaluate the short-term efficacy of an innovative multiple behavior screening, brief intervention and referral to treatment (MB-SBIRT) model using social images and future self-images to simultaneously link and reduce prescription and other co-occurring drug use behaviors among emerging adults in a primary care setting serving a racially and economically diverse community. The long term objective of this research is to cost-effectively reduce prescription and illicit drug abuse, along with alcohol and tobacco consumption, and improve health-related quality of life among high-risk emerging adults often ignored in intervention research and services.

Conditions

  • Drug Abuse

Interventions

BEHAVIORAL

MB-SBIRT (multiple behavior screening, brief intervention and referral to treatment) Online Program Brief

Online prevention program using positive images

BEHAVIORAL

MB-SBIRT (multiple behavior screening, brief intervention and referral to treatment) Online Program Extended Length

Online Program Extended Length

BEHAVIORAL

MB-SBIRT (multiple behavior screening, brief intervention and referral to treatment) Control

Control

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of Florida

    lead OTHER

Principal Investigators

  • Chudley E Werch, PhD · Addictive & Health Behaviors Research Institute, University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2011-06-30
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01439334 on ClinicalTrials.gov